Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06016543 · ClinicalTrials.gov registry record
Role of OMT in the Management of the Persistent Post-COVID-19 Symptoms
A clinical trial, sponsored by A.T. Still University of Health Sciences.
- Completed
- Registry status
- 7
- Enrollment target
NCT06016543: Completed study, sponsored by A.T. Still University of Health Sciences.
NCT06016543 is a clinical trial that has completed, run by A.T. Still University of Health Sciences. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06016543 has completed, sponsored by A.T. Still University of Health Sciences.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The goal of this observational study is to determine the feasibility of conducting a large-scale study on the effect of using osteopathic manipulative treatment (OMT) to treat patients with post-COVID-19 symptoms. The main questions it aims to answer are: 1. Is it feasible to conduct a large-scale study of the effect of OMT on patients with post-COVID-19 symptoms (based on how many patients agree to participate and how many complete the study)? 2. How much change in patients' post-COVID-19 symptom severity, quality of life, and ability to return to work can we expect to see following OMT? Participants will receive OMT as directed by their physician and complete questionnaires after every other OMT session. 1. Participants will complete questionnaires about their post-COVID-19 symptoms, quality of life, ability to return to work, and adverse events they experienced 3 days after every other OMT session. 2. Participants will be sent links to the questionnaires for 4 months or when their symptoms resolve, whichever comes first. 3. Additionally, participants will complete a follow-up questionnaire 2 months after they stop receiving OMT for their post-COVID-19 symptoms or 6 months after enrollment in the study, whichever comes first.
Primary Outcome
Proportion of patients who enroll in the study out of the number of patients who were eligible for and invited to enroll in the study.
Interventions
- PROCEDURE osteopathic manipulative treatment (OMT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2023-09-18 |
| Est. Completion | 2024-07-10 |
What the finished NCT06016543 record still lists
NCT06016543 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which osteopathic manipulative treatment (OMT) is the first listed.
NCT06016543 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06016543 about?
NCT06016543 is a clinical study titled "Role of OMT in the Management of the Persistent Post-COVID-19 Symptoms". The goal of this observational study is to determine the feasibility of conducting a large-scale study on the effect of using osteopathic manipulative treatment (OMT) to treat patients with post-COVID-19 symptoms. The main questions it aims to answer are: 1. Is it feasible to conduct a large-scale ...
What is the current status of trial NCT06016543?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2023-09-18. Estimated completion is 2024-07-10.
What interventions are being tested in trial NCT06016543?
The interventions under investigation include: osteopathic manipulative treatment (OMT) (PROCEDURE).
Who is sponsoring clinical trial NCT06016543?
This trial is sponsored by A.T. Still University of Health Sciences, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI